AzTrials
AzTrials

Development of Pulmonary Dysfunction Following Open Abdominal SurgeryPROVARNCT01683578

Protective Variable Ventilation for Open Abdominal Surgery

A study testing Variable Ventilation in people with Development of Pulmonary Dysfunction Following Open Abdominal Surgery, run by Technische Universität Dresden at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Variable ventilation has been shown to improve lung function and reduce lung damage as well as inflammation in different models of the acute respiratory distress syndrome. Also, variable ventilation is able to recruit lungs. Read more about this study

Who is it for?
Ages 18 to 85 years
What is being tested?
Variable Ventilation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteGermany
Study dates
Sep 2012to Sep 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • elective open abdominal surgery
  • ASA classification 2-3
  • age between 18 und 85 yrs
  • expected duration of surgery > 3 h
  • expected extubation in the operation room
  • written informed consent

Who cannot join

  • chronic lung disease (except to COPD stadium I and II, and asthma)
  • Body Mass Index (BMI) > 40
  • allergy to one of the drugs to be used for general anesthesia
  • participation in another interventional trial within 4 weeks before enrollment
  • addiction or any other disease that may interfere with the capacity of giving informed consent
  • pregnant or breastfeeding women
Show all 14Show fewer
  • women in reproductive age, except to those who fulfill one of the following:
  • post-menopause (12 months natural amenorrhoea, or 6 months amenorrhoea and serum FSH > 40 mlU/ml
  • post-operative (6 weeks after two-sided ovariectomy)
  • routine and correct use of anticonceptional methods with failure rate < 1 % per year
  • sexually not active
  • vasectomy of the partner
  • indication of low compliance with the protocol
  • contraindication for MRI examination

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Department of Anesthesiology and Intensive Care, University Hospital Carl Gustav Carus

    Dresden, Saxony, 01307

Other trials in Germany

About this study

Official title: Effects of Variable Tidal Volumes During Open Abdominal Surgery on Lung Function and Systemic Inflammation

Variable ventilation has been shown to improve lung function and reduce lung damage as well as inflammation in different models of the acute respiratory distress syndrome. Also, variable ventilation is able to recruit lungs. The present study will investigate whether variable as compared to non-variable ventilation improves post-operative lung function and reduces systemic inflammation in patients submitted to open abdominal surgery.

Being tested
Variable Ventilation
Keywords
mechanical ventilation, lung function, abdominal surgery, open, systemic inflammation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Variable VentilationOther

Study groups in NCT01683578
Study groupRoleWhat they receive
Variable VentilationActive comparatorVariable tidal volumes with mean at 8 mL/kg of predicted body weight
Receives: Other: Variable Ventilation
Non-variable VentilationNo interventionConventional mechanical ventilation with tidal volume 8 mL/kg of predicted body weight

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Forced vital capacity

    Forced vital capacity is assessed on the first postoperative day

    Measured: Preoperative until 5th postoperative day

Secondary outcomes (8)
  1. Arterial partial CO2 pressure

    PacO2 on the first postoperative day

    Measured: Preoperative until 5th postoperative day

  2. Peak expiratory flow

    Measured: Preoperative until 5th postoperative day

  3. Forced expiratory volume after 1 sec

    Forced expiratory volume after 1 sec (FEV1) on first postoperative day

    Measured: Preoperative until 5th postoperative day

  4. PaO2/FIO2

    PaO2/FIO2 during the intraoperative period

    Measured: Preoperative until 5th postoperative day

  5. Distribution of ventilation

    Distribution of ventilation in lungs

    Measured: Preoperative until 5th postoperative day

  6. Atelectasis

    Amount of lung atelectasis on the first postoperative day

    Measured: Preoperative until 5th postoperative day

  7. Postoperative pulmonary complications

    Development of postoperative pulmonary complications

    Measured: Preoperative until discharge from hospital

  8. Inflammation markers

    Concentrations of interleukine(IL)-6, IL-8 and tumor necrosis factor(TNF)-alpha in plasma

    Measured: Preoperative until 5th postoperative day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Sep 2012 (estimated)
  2. Study startSep 2012
  3. Primary completionSep 2013
  4. Study completionSep 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01683578
Sponsor's protocol ID
PulmEngineering-2012-01
Acronym
PROVAR
Status last verified
Mar 2016
First submitted
3 Sep 2012
Last updated
31 Mar 2016
Results posted
No
Data monitoring committee
No

Publications

  • Spieth PM, Guldner A, Uhlig C, Bluth T, Kiss T, Conrad C, Bischlager K, Braune A, Huhle R, Insorsi A, Tarantino F, Ball L, Schultz MJ, Abolmaali N, Koch T, Pelosi P, Gama de Abreu M; PROtective Ventilation (PROVE) Network. Variable versus conventional lung protective mechanical ventilation during open abdominal surgery (PROVAR): a randomised controlled trial. Br J Anaesth. 2018 Mar;120(3):581-591. doi: 10.1016/j.bja.2017.11.078. Epub 2017 Dec 1.

    PubMed 29452815
  • Spieth PM, Guldner A, Uhlig C, Bluth T, Kiss T, Schultz MJ, Pelosi P, Koch T, Gama de Abreu M. Variable versus conventional lung protective mechanical ventilation during open abdominal surgery: study protocol for a randomized controlled trial. Trials. 2014 May 2;15:155. doi: 10.1186/1745-6215-15-155.

    PubMed 24885921

Questions about this trial

What is this clinical trial studying?

A study testing Variable Ventilation in people with Development of Pulmonary Dysfunction Following Open Abdominal Surgery, run by Technische Universität Dresden at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Mar 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Forced vital capacity (time frame: Preoperative until 5th postoperative day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01683578, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Mar 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in